These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29749533)

  • 1. EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non‑small cell lung cancer cells.
    Lin C; Qin Y; Zhang H; Gao MY; Wang YF
    Oncol Rep; 2018 Jul; 40(1):29-38. PubMed ID: 29749533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
    Chen W; Lu J; Qin Y; Wang J; Tian Y; Shi D; Wang S; Xiao Y; Dai M; Liu L; Wei G; Wu T; Jin B; Xiao X; Kang TB; Huang W; Deng W
    Oncotarget; 2014 Dec; 5(23):11909-23. PubMed ID: 25481043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.
    Qin Y; Chen W; Xiao Y; Yu W; Cai X; Dai M; Xu T; Huang W; Guo W; Deng W; Wu T
    Oncotarget; 2015 Sep; 6(29):27130-45. PubMed ID: 26318425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor activates telomerase activity by direct binding of Ets-2 to hTERT promoter in lung cancer cells.
    Hsu CP; Lee LW; Tang SC; Hsin IL; Lin YW; Ko JL
    Tumour Biol; 2015 Jul; 36(7):5389-98. PubMed ID: 25680408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
    Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
    Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gefitinib Induces Apoptosis in NSCLC Cells by Promoting Glutaminolysis and Inhibiting the MEK/ERK Signaling Pathway.
    Zhang Y; Liu H; Liu X; Lang L
    Discov Med; 2024 Apr; 36(183):836-841. PubMed ID: 38665031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells.
    Ikari A; Sato T; Watanabe R; Yamazaki Y; Sugatani J
    Biochim Biophys Acta; 2012 Jun; 1823(6):1110-8. PubMed ID: 22546605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importin 13 promotes NSCLC progression by mediating RFPL3 nuclear translocation and hTERT expression upregulation.
    Zohud BA; Guo P; Zohud BA; Li F; Hao JJ; Shan X; Yu W; Guo W; Qin Y; Cai X
    Cell Death Dis; 2020 Oct; 11(10):879. PubMed ID: 33082305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
    Leu CM; Chang C; Hu C
    Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying the synergistic interaction of erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, with the multitargeted antifolate pemetrexed in non-small-cell lung cancer cells.
    Giovannetti E; Lemos C; Tekle C; Smid K; Nannizzi S; Rodriguez JA; Ricciardi S; Danesi R; Giaccone G; Peters GJ
    Mol Pharmacol; 2008 Apr; 73(4):1290-300. PubMed ID: 18187583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cells.
    Giovannetti E; Labots M; Dekker H; Galvani E; Lind JS; Sciarrillo R; Honeywell R; Smit EF; Verheul HM; Peters GJ
    Curr Pharm Des; 2013; 19(5):927-39. PubMed ID: 22973961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.
    Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
    Oncol Rep; 2018 Nov; 40(5):2944-2954. PubMed ID: 30226581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by depsipeptide FK228 coincides with inhibition of survival signaling in lung cancer cells.
    Yu XD; Wang SY; Chen GA; Hou CM; Zhao M; Hong JA; Nguyen DM; Schrump DS
    Cancer J; 2007; 13(2):105-13. PubMed ID: 17476138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor.
    Li S; Liu Z; Zhu F; Fan X; Wu X; Zhao H; Jiang L
    Oncol Res; 2013; 21(3):137-44. PubMed ID: 24512728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Ras-ERK pathway in mitotic COS7 cells is due to the inability of EGFR/Raf to transduce EGF signaling to downstream proteins.
    Shi H; Zhang T; Yi Y; Ma Y
    Oncol Rep; 2016 Jun; 35(6):3593-9. PubMed ID: 27004682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of plasmid-mediated RNA interference targeting telomerase reverse transcriptase on lung cancer cells.
    Ge L; Deng Z; Zhang Y; Shao W; Qiu Y; Cui D; Huang D
    Oncol Rep; 2011 Dec; 26(6):1487-95. PubMed ID: 21922145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells.
    Zheng F; Wu J; Zhao S; Luo Q; Tang Q; Yang L; Li L; Wu W; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):41. PubMed ID: 25948105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
    Dai B; Yan S; Lara-Guerra H; Kawashima H; Sakai R; Jayachandran G; Majidi M; Mehran R; Wang J; Bekele BN; Baladandayuthapani V; Yoo SY; Wang Y; Ying J; Meng F; Ji L; Roth JA
    PLoS One; 2015; 10(6):e0123967. PubMed ID: 26053020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR.
    Wang Y; Zhang P; Liu Z; Wang Q; Wen M; Wang Y; Yuan H; Mao JH; Wei G
    Mol Cancer; 2014 Nov; 13():252. PubMed ID: 25413624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.